IC
QNRX

Ikarian Capital’s Quoin Pharmaceuticals QNRX Stock Holding History

Ikarian Capital’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Hold
211,538
– – 0.11% 104
2026
Q1 		$1.4M Hold
211,538
– – 0.11% 107
2025
Q4 		$3.05M Buy
+211,538
New +$2.88M 0.24% 84
2025
Q1 		– Sell
-7,857
Closed -$179K – 205
2024
Q4 		$179K Buy
+7,857
New +$180K 0.02% 151

Other funds holding QNRX

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Ikarian Capital's QNRX Position: Q2 2026 in Review

Ikarian Capital held its Quoin Pharmaceuticals (QNRX) position steady in Q2 2026 at 211,538 shares worth $1.02M. The position accounts for 0.11% of the portfolio, ranked #104.

Ikarian Capital first reported a position in QNRX in Q4 2024 and has held it in 4 quarters since. The position peaked at $3.05M in Q4 2025. 20 funds tracked by Wall St. Rank hold QNRX as of Q2 2026.

  • Ikarian Capital held 211,538 shares of Quoin Pharmaceuticals worth $1.02M as of Q2 2026.
  • Ikarian Capital left its Quoin Pharmaceuticals share count unchanged in Q2 2026.
  • Quoin Pharmaceuticals made up 0.11% of Ikarian Capital's portfolio in Q2 2026, its #104 holding.
  • Ikarian Capital first reported a position in Quoin Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Ikarian Capital's Quoin Pharmaceuticals position peaked at $3.05M in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.